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CD24a Expression Levels Discriminate Langerhans
Cells from Dermal Dendritic Cells in Murine Skin and
Lymph Nodes
Susanne Stutte1,2, Bettina Jux1,2, Charlotte Esser1 and Irmgard Fo¨rster1
Langerhans cells (LCs) and dermal dendritic cells (dDCs) are the professional antigen-presenting cells of the
skin. Recently, their immunogenic versus tolerogenic role has come under re-investigation. LCs are
distinguished from dDCs by Langerin (CD207) staining or by detection of Birbeck granules. However, for
in vitro experiments it is desirable to have a simple and robust flow cytometric demarcation of both cell types.
We show here that CD24a is expressed on LCs but not on dDCs isolated directly from the skin. Moreover, in
combination with major histocompatibility complex class II (MHCII), CD24a expression levels distinguish LCs
from dDCs in skin-draining lymph nodes after antigen activation and migration. High expression of CD24a
correlated strictly with CD207 expression. MHCIIhigh cells were unique for skin-draining lymph nodes and were
shown to be the only cells carrying antigen after FITC painting of the skin. CD24a expression levels further
differentiated LCs and dDCs in the MHCIIhigh population. As staining for CD24a does not require fixation of
cells, CD24a-stained cells can be used for in vitro experiments to analyze and compare the functional roles and
properties of dDCs and LCs.
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INTRODUCTION
Dendritic cells (DCs) ensure transport of antigens captured
from peripheral tissues to the draining secondary lymphoid
organs, and are unique in their capacity to present antigen
and prime naive T lymphocytes. At least seven different
mouse CD11cþ DC subsets have been identified endowed
with different functional potential depending on their
phenotype and environment (Ardavin, 2003). Two of them
can be found in the skin and skin-draining lymph nodes
(sdLNs).
Langerhans cells (LCs) reside in an immunologically
immature state in the suprabasal layer of the epidermis,
where they detect invading pathogens or antigens (Romani
et al., 2003). They are characterized by their unique Birbeck
granules and Langerin expression (Valladeau et al., 2000).
LCs migrate as precursors from the blood through the dermis
to the epidermis. After antigen uptake they mature and leave
the skin through the dermis for the lymph node (LN) to initiate
an immune response or, alternatively, exert tolerogenic
functions (Steinman et al., 2003). The dermis harbors a
second DC subset, the dermal DC (dDC) or interstitial DC.
dDCs were shown to be important for skin immunity. They
are critically involved in the induction of an immune
response against haptens in the absence of epidermal LCs
(Bennett et al., 2005; Kissenpfennig et al., 2005), and initiate
protective T-cell responses to certain viral antigens (Allan
et al., 2003, 2006). LCs and dDCs express a mature
phenotype, characterized by high levels of major histocom-
patibility complex class II (MHCII) and costimulatory
molecules, when they constitutively migrate at a low rate
from the skin to sdLNs (Anjuere et al., 1999; Hemmi et al.,
2001). This homeostatic turnover increases under inflamma-
tory conditions. dDCs appear in the LN as early as 24 hours
after skin sensitization, whereas LCs require 3–4 days
to migrate from the epidermis into lymphoid organs
(Kissenpfennig et al., 2005).
Although it is known that MHCII-positive cells in the
epidermis are LCs, it is challenging to differentiate MHCII-
positive cells within the dermis, which comprise immature
LCs, mature LCs, and dDCs. This is of importance since the
unambiguous identification of LCs and dDCs is hampered by
their overlapping surface-marker expression profiles. So far,
only the differential expression of CD207 (Langerin) enables
the discrimination between LCs and resident dDCs. During
maturation, epidermal LCs internalize their Langerin from
the surface. Therefore, complex techniques of fixation and
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intracellular staining are necessary for LC identification,
which eliminates the possibility of further in vitro experi-
ments. To analyze and compare the functional roles of dDCs
and LCs directly ex vivo, a simple and clear-cut discrimina-
tion of both populations is desirable.
CD24 or ‘‘heat-stable antigen’’ is a pleiotropic, small,
variably glycosylated, glycosylphosphatidylinositol-linked
protein molecule. In the immune system, it was first reported
as a developmental marker in thymocytes and as a
costimulatory molecule for T cells (Liu et al., 1992). CD24a
has been shown to be expressed by murine DCs (Inaba et al.,
1992) and was found to act as a costimulatory molecule on
LCs (Enk and Katz, 1994). Here we demonstrate that the level
of CD24a expression clearly distinguishes epidermal LCs
from dDCs in the skin and sdLNs, and thus can be utilized to
separate LCs from dDCs for functional experiments.
RESULTS
CD24a expression coincides strictly with CD207 (Langerin)
expression on skin DCs
While the epidermis contains almost exclusively LCs, the
DCs in the dermis may be a mixture of migrating LCs and
dDCs. The procedure of isolating DCs from skin requires
enzymatic digestion with trypsin. Trypsin treatment led to the
degradation of CD11c from the cell surface within minutes
(data not shown), whereas MHCII expression was insensitive
to trypsin treatment (data not shown). Thus, CD11c, normally
the approved marker for analyzing DCs in the mouse, is not
useful to recognize DCs isolated from the skin.
We noted differential expression of CD24a in dermal
versus epidermal MHCIIþ cells. In contrast to CD11c,
trypsin did not affect CD24a expression (data not shown).
Therefore, we stained epidermal cell suspensions for MHCII,
CD207, and CD24a. As shown in Figure 1a, all epidermal
MHCII/CD207-positive cells (that is, LCs) also stained for
CD24a. As expected, there is no MHCIIþCD207 population
in the epidermis. Keratinocytes and T cells were also reported to
express CD24a. Figure S1 shows that 80% of keratinocytes and
12% of CD3þ T cells are positive for CD24a in untreated skin,
although the respective expression levels are lower than those of
LCs. Simultaneous staining for MHCII and CD24a thus allows a
very distinct discrimination of LCs in the epidermis.
In contrast, the dermis consists of different MHCIIþ
populations (Figure 1b), such as migrating LCs, resident
dDCs, monocytes, and macrophages. Accordingly, we
detected a small (0.5%) MHCIIþ CD207þ population and
a larger (5%) MHCIIþCD207 population in dermal cell
preparations. As shown in Figure 1b, virtually all MHCIIþ
CD207þ cells expressed CD24a (filled graph), whereas
CD207 cells were CD24a negative (black line). This latter
cell population contained approximately 20% CD14þ cells,
that is, monocytes/macrophages (data not shown).
We conclude that the cell-surface marker CD24a is specific
for LCs and can be used to distinguish LCs from resident
dDCs in the skin.
CD24a expression levels distinguish dDCs and LCs in sdLNs
Distinguishing immigrated LCs versus dDCs in the draining
LNs is important for studying skin-originated immune
responses. Migration to the LNs is accompanied by complex
processes of maturation of the DCs. We asked whether
CD24a could be used to distinguish LCs from dDCs after
migration to the LNs and stained sdLNs for MHCII, CD207,
and CD24a. As shown in Figure 2a, sdLNs harbored a
population of approximately 1% MHCIIhigh cells in contrast
to mesenteric LN. To determine whether these cells represent
skin-derived dendritic cell (sdDCs) (that is, LCs or dDCs), we
tracked them by painting a solution of FITC on the ventral
skin. Figure 2a shows that all FITCþ cells could be found
within the fraction of MHCIIhigh cells. Counterstaining with
CD24a revealed two populations, namely a CD24ahigh and a
CD24alow/int population, within the FITCþMHCIIhigh cells
(Figure 2b). Over time the percentage of CD24ahigh cells
increased up to 75% of all MHCIIhigh cells. Similar to CD24a,
the percentage of Langerin-positive cells increased to 75%
during the observation period (Figure 2c and f). Double
staining the cells for CD24a and Langerin showed that only
the CD24ahigh cells were CD207þ , whereas the CD24alow/int
cells were CD207 (Figure 2d). Figure 2e shows the staining
pattern of the whole LN cell suspension. The MHCIIhigh
CD24ahigh and MHCIIhighCD24alow/int cells can be easily
distinguished. Thus, dDCs appear to upregulate CD24a
during maturation and migration from the skin to the LNs,
albeit expression remains much lower than on LCs. Note also
that CD207þ LCs in the LNs express CD24a at a higher level
than in the skin (compare Figures 1 and 2b); the mean
fluorescence increases from 100 to 1,500 (Figure 2g).
Kinetics of CD24ahigh cells immigrated from skin follows the
pattern known for dDCs and LCs
We analyzed the expression of CD24a/CD207 on cells in
the sdLNs up to 4 days after FITC sensitization of the skin.
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Figure 1. CD24a expression by DCs of the epidermis and dermis. Epidermis
and dermis were separated by trypsin treatment and single-cell suspensions
were analyzed by FACS. (a) Epidermal cells were stained for MHCII and
CD207. Double positive cells were further analyzed for CD24a expression
(filled graph). (b) CD24a expression in the dermis was analyzed in the
population positive for MHCII and CD207 (filled graph), as well as in the
MHCIIþ CD207 fraction (black line). Gray line represents the isotype
control. Data are representative of three independent experiments.
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As shown in Figure 2b and d, the CD24ahigh as well as the
CD207þ population from all FITCþMHCIIhigh cells in the LN
increased from approximately 25% at day 1 to 75% at day 4,
whereas the population of CD24alow/intCD207 cells decreased
proportionately after day 1 (Figure 2f). This pattern confirms
previous data on different migration kinetics of LCs and dDCs
(Kissenpfennig et al., 2005). Taken together, our data show that
MHCIIhighCD24high staining discriminates LCs from dDCs in the
LNs, while dDC can be identified by MHCIIhighCD24low/int
expression from other MHCIIþ cells in the LNs.
CD24a expression on sdDCs versus blood-derived DCs in LNs
sdLNs harbor activated DCs, immigrated after antigenic
activation, but also constitutively circulating DCs, which
express CD11c, CD8a, and MHCII (Carbone et al., 2004, and
our own data, not shown). Also called ‘‘blood derived’’, some
of these CD8aþ DCs can be CD207þ (Douillard et al., 2005;
Kissenpfennig et al., 2005).
To determine whether CD207 expression on these cells
also correlates with CD24ahigh expression, we enriched DCs
from sdLNs using a density gradient (Figure 3a). Of all
CD11cþCD8aþ cells, 12% were positive for CD207 (data
not shown). Staining for CD24a and CD207 further showed
that all blood-derived DCs, which are CD207þ , are indeed
CD24ahigh cells (gray-shaded histogram in Figure 3b).
However, we also found some CD8aþCD24ahigh DCs that
were negative for CD207 (thin line).
LCs and dDCs express high levels of CD40
The combination of CD11c and CD40 has been described
previously to allow discrimination of LCs from dDCs after
enrichment on a density gradient (Ruedl et al., 2000). In order
to confirm and extend this finding, we counterstained CD40/
CD11c-stained LN cells with the specific marker CD207 after
a density gradient enrichment. In this experiment we induced
active immigration of skin DCs by sensitizing the abdominal
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Figure 2. CD24a expression by sdDCs in LNs. Mice were shaved on the ventral skin and painted with FITC or solvent as control. A total of 24, 48, and
96hours after application, sdLNs and mesenteric LNs were harvested and cells were analyzed by FACS. (a) sdDCs can be identified as FITC-positive MHCIIhigh.
Shown are the dot plots of cells isolated 24hours after application of FITC or solvent alone (control). (b) The FITCþ MHCIIhigh cells were analyzed for
CD24a expression. The dot plot shows a representative CD24a staining pattern of MHCIIhigh cells 24 hours after FITC application. The percentage of
CD24high cells was calculated for all time points (n¼ 3). (c) After staining of lymph node cells with Langerin and MHCII, the frequency of Langerinþ cells within
the FITCþ MHCIIhigh fraction was calculated for all different time points after FITC application. (d) The dot plots are representative for the expression of
CD24a and CD207 on FITCþ cells in sdLNs at the indicated time points. The frequencies shown in the figure are representative of three independent
experiments. (e) The staining pattern of the whole sdLN cell suspension was analyzed at different time points. MHCII and CD24a expression is shown as well as
the distribution of CD24ahigh and CD24alow/int cells within the MHCIIhigh population. One out of three independent experiments is depicted here. (f) Frequency
of CD24low/int dDCs and CD24ahigh LCs within the MHCIIhigh cell population depending on the time after FITC application on the skin. (g) The mean
fluorescence intensity of CD24a was compared between LCs in the epidermis and those in the sdLNs. *** indicates Po0.0001.
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skin with the hapten FITC, and analyzed draining LNs after
2 and 4 days for CD11c, CD40, CD207, and CD24a. Forty-
eight and 96 hours after sensitization, we could identify
a distinct difference in LC frequency between the popula-
tions A and B (Figure 4a) In both populations Langerin-
expressing cells are present, the major being within the
CD40highCD11chigh cell fraction (almost 70%). However,
since CD207þCD24ahigh cells were also present within
population A, we conclude that staining for CD207 or CD24a
is more suitable for discrimination of LCs and dDCs than the
expression level of CD11c.
DISCUSSION
In the skin, at least two types of professional antigen-
presenting cells are known, the LCs and the dDCs.
Differential functions of these cell populations have been
suggested, and lead to increased investigation into their
tolerogenic versus immunogenic potential. Recently, induci-
ble LC ablation was achieved by diphtheria toxin treatment
of knock-in mice generated to express the diphtheria
toxin receptor under the control of the CD207 promoter
(Bennett et al., 2005; Kissenpfennig et al., 2005). This
approach produced two different results. On the one hand,
LCs were dispensable for triggering hapten-specific T-effector
cells (Kissenpfennig et al., 2005); on the other hand, contact
hypersensitivity responses in LC-depleted mice were signifi-
cantly decreased (Bennett et al., 2005). In contrast, perma-
nent ablation of LCs by direct transgenic diphtheria toxin
expression in CD207þ cells resulted in an enhanced contact
hypersensitivity reaction (Kaplan et al., 2005). These elegant
experimental designs permit analysis of the function of dDCs
in the absence of LCs and show that LCs might possess
immunogenic as well as tolerogenic potential.
A technical difficulty in studying sdDCs is their isolation
and phenotypic characterization in situ, ex vivo, and after
migration to the LNs. Until now, the extra- and intracellular
marker Langerin (CD207) has been used for LC identification.
CD207 is a C-type lectin associated with the formation of
Birbeck granules, which are unique for LCs. CD207 is a
problematic marker as it is internalized during maturation
and thus impossible to use for isolation of live cells. Although
the identification of LCs is possible by staining for Langerin,
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Figure 3. Blood-derived CD8aþ DCs were analyzed for CD24a expression
under steady-state conditions. sdLNs of untreated mice were harvested. DCs
were enriched by density gradient centrifugation and stained for CD11c,
CD8a, CD207, and CD24a. (a) Staining pattern for CD8a and CD11c after
DC enrichment. The frequency of CD8aþCD11cþ DCs is indicated.
(b) CD24a expression on gated CD11cþCD8aþCD207 cells (thin black
line) and CD11cþCD8aþCD207þ cells (gray filled histogram) is compared
with that of all CD11cþCD207þ cells (thick black line) considered as
control. The dotted line represents the isotype control.
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Figure 4. Comparison of the CD40/CD11c expression pattern with CD207/
CD24a staining. Ventral skin of C57BL/6 mice was painted with 200 ml of
0.5% FITC to induce active migration of sdDCs to the sdLNs. After 48 and
96hours, sdLNs were harvested and DCs were enriched by density-gradient
centrifugation, and stained for CD40, CD11c, CD24a, and CD207.
(a) The representative 48-hour dot plot depicts the CD11cþCD40high (A)
and CD11chighCD40high (B) populations. These cells were further analyzed
for CD207 and CD24a expression at the indicated time points.
(b) The percentages of CD24ahigh and CD207þ cells were calculated for
population A (thick black line) and B (thin black line).
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the differential detection of dDCs remains challenging
(Valladeau and Saeland, 2005). Therefore, we looked for an
alternative method to distinguish sdLCs from dDCs, which is
difficult because of their overlapping phenotype (Anjuere
et al., 1999; Valladeau et al., 2002). We here describe that
the surface molecule CD24a is differentially expressed on
LCs versus dDCs (i) within the skin and (ii) after migration to
sdLNs. Since CD11c, the classical surface marker to identify
DCs, is destroyed by trypsin treatment during isolation, we
used MHCII expression to identify sdDCs. Sensitivity
for trypsin was also described for DEC205 (Anjuere et al.,
1999), which is normally expressed more strongly by LCs
than by dDCs.
It has been known for long that CD24a is expressed by
various antigen-presenting cells, including DCs and LCs
(Bruce et al., 1981; Takei et al., 1981; Inaba et al., 1992), or
by keratinocytes (Erdmann et al., 1995; Figure S1). Already in
1994, Enk and Katz (1994) reported a costimulatory function
of CD24a on LCs for T-helper 1 cell-dependent cutaneous
immune reactions. However, they did not explore the use of
CD24a in identification, tracking, or isolation of LCs versus
dDCs from skin, or after migration to the LNs. Here, we report
a strict correlation of CD24a with CD207 expression, and
differential expression of CD24a in LCs versus dDCs. Other
CD24aþ cells such as activated T cells, which migrate into
the skin, do not express MHCII. In any case, these and other
CD24aþ cells bear other lineage-specific surface molecules
and are distinguishable from LCs and dDCs.
Some blood-derived DCs were described to be CD207
positive (Kissenpfennig et al., 2005). We could demonstrate
that this CD207 expression correlates with CD24ahigh
expression. Although a fraction of CD207 blood-derived
DCs is also CD24ahigh, these cells are not MHCIIhigh and can
therefore easily be separated from sdDCs.
An alternative staining pattern for sdDCs was previously
described by Ruedl et al. (2000), where CD11chighCD40high
cells were found to be LCs. After FITC painting of the skin, we
could confirm that all FITC-positive cells were within the
CD40highCD11cþ and CD11chigh populations, but it was not
possible to discriminate dDCs from LCs without additional
staining. All FITC-positive cells were MHCIIhigh. This result is
congruent with those of Ohl et al. (2004) who demonstrated
that under steady-state conditions MHCIIhigh cells are sdDCs.
Additionally, the combination of CD24a and MHCII dis-
criminated between LCs and dDCs.
Although different DC subsets display specific functional
and phenotypic features, they share a characteristic pheno-
typic profile; in the mouse, conventional DCs are considered
to be MHCIIþ , CD11cþ , CD40þ , CD86þ , CD3, B220,
Ig, and Gr1 (Anjuere et al., 1999). We here add CD24a
as a marker whose expression levels distinguish two
DC populations in the skin and sdLNs. CD207þ cells
can also be found in spleen and mesenteric LNs, suggesting
an uncharacterized population unrelated to epidermal LCs
or a population of LCs with differing trafficking
properties (Anjuere et al., 1999; Valladeau et al., 2002;
Stoitzner et al., 2003; Kissenpfennig et al., 2005).
Using CD24a as an additional marker in multi-parameter
surface staining, it will be possible to analyze aberrant LC
trafficking further.
Little is known about the regulation of CD24a expression.
We noted increased expression of CD24a in LCs and dDCs
after sensitization and migration to LNs. CD24a expression
might be related to the migratory or homing behavior of
LCs/dDCs, either as cause or effect. However, when LCs were
taken in culture (where they mature), they exhibited reduced
CD24a expression (Enk and Katz, 1994).
In conclusion, we have shown that the CD24a expression
level in combination with MHCII is a distinguishing surface
marker for skin-resident LCs and dDCs, as well as for
activated LCs and dDCs in sdLNs. This method will be useful
in analyzing the biology of LCs/dDCs ex vivo further. The
functional role of differential CD24a expression, for example,
in relation to the immunogenic and tolerogenic potential of
these two cell types needs to be explored in future.
MATERIALS AND METHODS
Mice
Female C57BL/6 mice (Harlan Winkelmann GmbH, Borchen,
Germany) were kept in the animal facility at the IUF, Du¨sseldorf,
under specific pathogen-free conditions. Mice used were 7–12
weeks old.
Isolation of dDCs and epidermal LCs
The hair of the dorsal skin was removed with forceps and the skin
sample was washed with 70% alcohol. Subcutaneous fat was
scraped off with a scalpel. Skin pieces were placed on 0.25%
trypsin/phosphate-buffered saline for 2 hours at 371C. The epidermal
layer was peeled from the underlying dermis and floated in RPMI-
1640 supplemented with 10% heat-inactivated fetal calf serum,
2mM L-glutamine, 5 105 M 2-mercaptoethanol, 0.15% (w/v)
sodium hydrogen carbonate, 1mM sodium pyruvate, 1mM non-
essential amino acids, 100 Uml1 penicillin, and 100 mgml1
streptomycin (PAA Laboratories GmbH, Coelbe, Germany), hereafter
referred to as complete medium. Epidermal cells were released by
breaking up epidermal sheets with forceps, followed by vigorous
pipetting. The dermis was further incubated for 40minutes at 371C
with 0.5mgml1 collagenase P (Roche, Mannheim, Germany) and
300Uml1 DNaseI (Roche) in RPMI-1640. The reaction was
stopped with complete medium.
FITC painting
Mice were shaved on the abdomen and painted with 200 ml 0.5%
FITC in acetone–dibutylphthalate (Sigma, Deisenhofen, Germany).
After 24, 48, and 96 hours axillary, brachial, and inguinal LNs
(referred to as sdLNs) were harvested. Mesenteric LNs were also
harvested and served as negative control to detect the presence of
LCs and dDCs. Single-cell suspensions were prepared from the LNs
by incubation with collagenase D (Roche) and DNaseI (Roche) for
20min. Cells were washed and stained for flow cytometry. Animal
experiments were performed with permission from the Bezirksre-
gierung Du¨sseldorf (Az.: 50.05-230-79/05).
Density gradient enrichment
LN cell suspensions were enriched for DCs by using the nycodenz
gradient (Optiprep; Sigma) for 15minutes at room temperature. The
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method was performed as described before (Ruedl et al., 2000).
Cells were washed once and analyzed by flow cytometry.
Flow cytometry
The following monoclonal anti-mouse antibodies were used: anti-
CD11c FITC (clone N418), anti-CD24a FITC and phycoerythrin
(clone M1/69), anti-CD14 phycoerythrin (clone rmC5-3), anti-CD40
phycoerythrin (clone 3/23), anti-CD8a phycoerythrin (clone 53–6.7),
and PerCP-conjugated streptavidin (from BD Biosciences, Heidelberg,
Germany); anti-CD11c allophycocyanin (APC) (N418) and
anti-I-A/I-E APC (clone M5/114.15.2) (from eBioscience), San Diego,
CA); and biotinylated anti-CD207 (clone 926G4) (from AbCyS,
Paris, France).
A total of 2 106 cells were preincubated with unconjugated
anti-CD16/32 before staining to block Fc-receptors. For intracellular
staining, cells were fixed with 2% paraformaldehyde (PFA) in
phosphate-buffered saline and permeabilized by 0.5% saponin in
1% BSA in phosphate-buffered saline. All stainings were performed
for 15minutes at 41C. Data were analyzed with a FACSCalibur in list
mode, using CellQuest software and WinMDI. Live cells were gated
using forward and sideward scatter.
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